Interés Humano

Vacuna contra la covid-19 de compañía estadounidense Novavax inicia fase final de ensayo clínico

Se trata de la undécima vacuna que alcanza este nivel de desarrollo

(FILES) In this file photo three potential coronavirus, COVID-19, vaccines are kept in a tray at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - US biotech firm Novavax said Ton September 24, 2020 it was initiating its final Phase 3 clinical trial for its experimental Covid-19 vaccine. The trial will be carried out in the United Kingdom and aims to enroll 10,000 volunteers, aged 18-84, with and without underlying conditions, over the next four to six weeks. (Photo by ANDREW CABALLERO-REYNOLDS / AFP)
(FILES) In this file photo three potential coronavirus, COVID-19, vaccines are kept in a tray at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. - US biotech firm Novavax said Ton September 24, 2020 it was initiating its final Phase 3 clinical trial for its experimental Covid-19 vaccine. The trial will be carried out in the United Kingdom and aims to enroll 10,000 volunteers, aged 18-84, with and without underlying conditions, over the next four to six weeks. (Photo by ANDREW CABALLERO-REYNOLDS / AFP) ANDREW CABALLERO-REYNOLDS
‌
‌

‌

‌
‌

‌

‌